Skip to content
healthcare.dev

Kalydeco

NDC 51167-400, ivacaftor, granule, from Vertex Pharmaceuticals Incorporated.

Product NDC
51167-400
Status
Listed
Labeler
Vertex Pharmaceuticals Incorporated
Dosage form
GRANULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA207925
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/51167-400 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • IVACAFTOR75 mg/1

Pharmacologic classes

Chloride Channel Activation Potentiators [MoA]; Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC]; Cytochrome P450 2C9 Inhibitors [MoA]; Cytochrome P450 3A Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]

Package NDCNDC-11Package
51167-400-015116704000156 GRANULE in 1 CARTON (51167-400-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/0ab0c9f8-3eee-4e0f-9f3f-c1e16aaffe25

Use it

Look up 51167-400 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/51167-400 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 51167-400. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.